LIK066
CLIK066X2204
Phase 2 small_molecule completed
Quick answer
LIK066 for Obese Patients With Non-alcoholic Steatohepatitis (NASH) is a Phase 2 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Obese Patients With Non-alcoholic Steatohepatitis (NASH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed